Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre.
about
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver InjuryCauses, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospitalHepatotoxicity Due to Antituberculosis Therapy among Paediatric Patients Seen at the University of Ilorin Teaching Hospital, North Central Nigeria.Treatment delay and fatal outcomes of pulmonary tuberculosis in advanced age: a retrospective nationwide cohort studyPolymorphism of PXR gene associated with the increased risk of drug-induced liver injury in Indonesian pulmonary tuberculosis patients.Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis TreatmentAdverse Events in Treating Smear-Positive Tuberculosis Patients in China.Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish LarvaeThe trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease.Drug-induced liver injury: what was new in 2013?Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity.Nucleoside analogs and tuberculosis: new weapons against an old enemy.The pharmacological challenges of treating tuberculosis and HIV coinfections.Mycobacterium tuberculosis nucleic acid amplification tests reduce nosocomial tuberculosis exposure in intensive care units: A nationwide cohort study.Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India.Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan.Pyrazinamide Induced Rat Cholestatic Liver Injury through Inhibition of FXR Regulatory Effect on Bile Acid Synthesis and Transport.Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study.Investigating the CYP2E1 Potential Role in the Mechanisms Behind INH/LPS-Induced Hepatotoxicity.Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.Herb-Induced Liver Injuries in Developing Nations: An Update
P2860
Q26749054-47A60396-5D52-4D6B-9F12-331FD44C5743Q26772063-A49C74C1-D4D6-47D5-990D-A8BFDF5668FDQ33716365-19AA4A08-713A-4BDE-B8B8-FD819AE48169Q33831159-D4355E64-F93E-4AEB-987C-7A68F47B469BQ35791410-63DC5A29-2524-4B17-9D5A-D3E8E46A27D1Q36194503-76405444-3AF1-4981-8895-01856C5575ACQ36513139-94D3AADB-13DE-4D9C-8B71-49FE2520651FQ37428683-660AF36D-2138-4482-9368-4CAC557D9669Q37431272-F1B30E96-1052-4A8A-98E5-5BDF0C9AA3B2Q38205591-829C10A9-B4F6-45E9-ACD9-784F8345F657Q38208324-3A6CF15A-35C8-461A-BA0C-091FD5D65261Q38360770-1FF84774-184D-4DBB-A84D-09F967C671CCQ38397331-5B5C2423-FDF5-441C-B816-D3BEB5A199CCQ39003762-BC7D734E-1E07-4FB2-8A46-7740390A66B5Q40465863-BBFC89FF-C04C-459F-8CC3-2159BC715D91Q40723805-5052921A-9577-48DF-9452-9A06E996D66EQ42357130-F9D5083E-5CCB-4D5F-95DE-6D3514882D26Q42696407-8CCA2E05-2D7D-466D-A0F7-5A5D3D1673FCQ48121559-F308B6EA-04AB-4F74-A075-3EF2EBCAE364Q51736892-DEFD55D0-2FF3-4FB2-94F3-5173D8E039CAQ52625145-43DA37DB-028E-4C74-A5AB-A27E6B9E3843Q56912365-576BB8C4-34D1-4EAD-B49A-BB6BBA460736
P2860
Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Hepatotoxicity due to first-li ...... ce in a Taiwan medical centre.
@en
Hepatotoxicity due to first-li ...... ce in a Taiwan medical centre.
@nl
type
label
Hepatotoxicity due to first-li ...... ce in a Taiwan medical centre.
@en
Hepatotoxicity due to first-li ...... ce in a Taiwan medical centre.
@nl
prefLabel
Hepatotoxicity due to first-li ...... ce in a Taiwan medical centre.
@en
Hepatotoxicity due to first-li ...... ce in a Taiwan medical centre.
@nl
P2093
P50
P356
P1476
Hepatotoxicity due to first-li ...... nce in a Taiwan medical centre
@en
P2093
P304
P356
10.5588/IJTLD.12.0782
P577
2013-07-01T00:00:00Z